{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Effect+Neonatal&page=22", "query": { "condition": "Effect Neonatal", "page": 22 }, "page_size": 10 }, "pagination": { "page": 22, "page_size": 10, "total_count": 856, "total_pages": 86, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Effect+Neonatal&page=23&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Effect+Neonatal&page=21&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T06:35:51.344Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05418049", "title": "Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fragile X Syndrome" ], "interventions": [ { "name": "Baclofen", "type": "DRUG" }, { "name": "Memantine", "type": "DRUG" }, { "name": "Roflumilast", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 45, "start_date": "2022-09-08", "completion_date": "2026-03-05", "has_results": false, "last_update_posted_date": "2025-12-23", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05418049" }, { "nct_id": "NCT02784821", "title": "Antibiotic \"Dysbiosis\" in Preterm Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Enterocolitis, Necrotizing", "Bacteremia", "Bronchopulmonary Dysplasia", "Intraventricular Hemorrhage", "Periventricular Leukomalacia", "Chronic Lung Disease", "Ileal Perforation" ], "interventions": [ { "name": "Antibiotic", "type": "DRUG" }, { "name": "Gastric fluid", "type": "OTHER" }, { "name": "Breast milk", "type": "OTHER" }, { "name": "Stool samples", "type": "OTHER" }, { "name": "Antibiotics", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "23 Weeks", "maximum_age": "33 Weeks", "sex": "ALL", "summary": "23 Weeks to 33 Weeks" }, "enrollment_count": 98, "start_date": "2017-01-16", "completion_date": "2019-09-11", "has_results": true, "last_update_posted_date": "2024-06-05", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02784821" }, { "nct_id": "NCT05899816", "title": "A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis", "Moderate-to-severe Atopic Dermatitis" ], "interventions": [ { "name": "Rocatinlimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "54 Years", "sex": "ALL", "summary": "18 Years to 54 Years" }, "enrollment_count": 221, "start_date": "2023-06-07", "completion_date": "2024-11-14", "has_results": true, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 72, "location_summary": "Scottsdale, Arizona • Tempe, Arizona • Little Rock, Arkansas + 61 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05899816" }, { "nct_id": "NCT00719381", "title": "Effect of Pioglitazone on Inflammation in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paul Beringer", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2008-01", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2012-06-14", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00719381" }, { "nct_id": "NCT01743001", "title": "Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Arterial Hypertension" ], "interventions": [ { "name": "Macitentan 10 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actelion", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 226, "start_date": "2013-05-21", "completion_date": "2016-12-01", "has_results": true, "last_update_posted_date": "2018-02-23", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 7, "location_summary": "Los Angeles, California • Palo Alto, California • Atlanta, Georgia + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT01743001" }, { "nct_id": "NCT00076102", "title": "Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neurofibromatosis 1", "Neurofibroma, Plexiform" ], "interventions": [ { "name": "Pirfenidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "3 Years to 21 Years" }, "enrollment_count": 36, "start_date": "2004-07-21", "completion_date": "2010-04-01", "has_results": true, "last_update_posted_date": "2018-04-23", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Washington D.C., District of Columbia • Chicago, Illinois + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00076102" }, { "nct_id": "NCT06413537", "title": "Study of SPG601 in Adult Men With Fragile X Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fragile X Syndrome" ], "interventions": [ { "name": "SPG601", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spinogenix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 10, "start_date": "2024-07-05", "completion_date": "2024-12-31", "has_results": true, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06413537" }, { "nct_id": "NCT00842621", "title": "Long Term Effects of Erythrocyte Lysis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sickle Cell Disease", "Hemolytic Anemia" ], "interventions": [ { "name": "Clinical Evaluations", "type": "PROCEDURE" }, { "name": "Laboratory Studies", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 390, "start_date": "2009-03", "completion_date": "2016-06", "has_results": false, "last_update_posted_date": "2016-06-27", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00842621" }, { "nct_id": "NCT00140998", "title": "Estrogen Treatment (Oral vs. Patches) in Turner Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Turner Syndrome", "Hypogonadism", "Premature Ovarian Failure" ], "interventions": [ { "name": "17 beta estradiol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nemours Children's Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "16 Years", "sex": "FEMALE", "summary": "10 Years to 16 Years · Female only" }, "enrollment_count": 16, "start_date": "2001-01", "completion_date": "2004-06", "has_results": false, "last_update_posted_date": "2017-11-30", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00140998" }, { "nct_id": "NCT00788047", "title": "A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Huntington Disease", "Alzheimer Disease" ], "interventions": [ { "name": "Dextromethorphan", "type": "DRUG" }, { "name": "Dimebon + Dextromethorphan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 14, "start_date": "2008-11", "completion_date": "2009-01", "has_results": false, "last_update_posted_date": "2009-03-09", "last_synced_at": "2026-10-28T06:35:51.344Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00788047" } ] }